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Cardiovascular disease (CVD) is associated with many risk factors including oxidative stress and 
dyslipidaemia. The current work evaluated the effects of antioxidants supplementation on salt-induced 
dyslipidaemia in albino rats. Rats were divided into 10 groups of 7 rats each.  Groups 2-10 were fed 8% salt 
diets for 5 weeks while group 1 served as control and were fed normal rat feed. Water was provided to all the 
groups ad libitum. The animals in groups 3-10 were then supplemented with vitamin A; vitamin C; vitamin E; 
Cu; Mn; Zn; vitamins A, C and E combined and Cu, Mn and Zn combined respectively for additional 4 weeks 
simultaneously with salt loading. Group 2 was not supplemented and served as the negative control. Serum 
levels of total cholesterol, triacylglyceride, low density lipoprotein (LDL) cholesterol, very low density 
lipoprotein (VLDL) cholesterol, high density lipoprotein (HDL) cholesterol and glucose were estimated. The 
results indicated that the vitamins reduced significantly serum lipid profiles and the atherogenic index by up to 
80%. The serum glucose levels of the rats supplemented with antioxidant vitamins and minerals were also 
significantly (P<0.05) lowered compared with the negative control group. These results suggest that the 
reduction of serum lipid profile and glucose level may be due to regulation of cholesterol and lipoprotein 
metabolism and increased insulin sensitivity as a result of the supplementations. It may thus suggest that the 
antioxidants may provide protection against CVDs and metabolic syndrome in salt-induced dyslipidaemia in 
rats.  
© 2012 International Formulae Group. All rights reserved. 
 





Accumulating evidence indicates that 
oxidative stress through over production of 
reactive oxygen (ROS) and nitrogen species 
(RNS) or antioxidants deficiency plays a 
major role in the initiation and progression of 
cardiovascular dysfunction associated with 
diseases and conditions such dyslipidaemia, 
development of insulin resistance, β-cell 
dysfunction, impaired glucose tolerance and 
eventual development of type 2 diabetes, 
ischemic heart disease, chronic heart failure 
and hypertension (Grossman, 2008; Rodrigo, 
2007).  ROS are generated in aerobic 
organisms during physiological or 
physiopathological oxidative metabolism of 
mitochondria. ROS may react with a variety 
of biomolecules, including lipids, 
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carbohydrates, proteins, nucleic acids, and 
macromolecules of connective tissue, thereby 
interfering with cell functions. Under normal 
physiological conditions, there is a critical 
balance in the generation of oxygen free 
radicals and antioxidant defense systems. 
Impairment in the oxidant/antioxidant 
equilibrium provokes a situation of oxidative 
stress and generally results from hyper 
production of ROS. Oxidative stress is known 
to be a component of molecular and cellular 
tissue damage mechanisms in a wide spectrum 
of human diseases (Valko et al., 2007). 
Previous studies have demonstrated 
that elevated dietary salt intake leads to an 
impaired relaxation of blood vessels to 
endothelium-dependent relaxations induced 
by a variety of vasodilator agents (Bragulat et 
al., 2001; Campese, 1994; Boegehold, 1993; 
Guzik, 2002; Lenda et al., 2000). A possible 
contributor to impaired vascular relaxation to 
dilator stimuli in animals on a high-salt diet is 
an impaired function of the endothelium. An 
increase in blood pressure (BP) in response to 
dietary sodium (salt sensitivity) is a well-
documented phenomenon in humans and is 
considered to be an important factor in the 
pathogenesis of hypertension ((Bragulat et al., 
2001). In animal models of salt-sensitive 
hypertension, the increase in BP after salt 
loading is characterized by reduced nitric 
oxide production Campese et al., 1996; 
Fujiwara et al., 2000). Similarly, in humans 
with salt-sensitive hypertension, salt loading 
was associated with decreased plasma and 
urinary levels of nitric oxide metabolites. A 
variety of evidence suggests that reactive 
oxygen species contribute to impaired 
endothelial function in several forms of 
hypertension and that there is increased 
oxidative stress in the microvessels of 
spontaneously hypertensive rats and Dahl salt-
sensitive hypertensive rats (Swei et al., 1997; 
Manning et al., 2003).  A recent report by 
Lenda et al. (2000) has suggested that reactive 
oxygen species can also contribute to reduced 
endothelium-dependent dilation in 
normotensive rats on a high-salt diet. 
Dyslipidaemia is defined as an 
abnormal lipids status. Common abnormalities 
include elevated levels of total cholesterol, 
low density lipoprotein cholesterol (LDL c), 
Lp(a) and triglyceride; low levels of high 
density cholesterol (HDL c) and a 
preponderance of small dense LDL particles. 
These abnormalities can be found alone or in 
combination. Dyslipidemia, very common in 
patients with type 2 diabetes is one of the risk 
factors of cardiovascular disease. Many 
studies have indicated that in diabetes it is not 
glycemia but hypertension, serum lipids, and 
body mass index that are independently 
associated with the risk of developing diabetic 
neuropathy (Brismar et al., 2007). Increased 
levels of plasma lipids, either causative of or 
subsequent to the development of diabetes, act 
in concert with both oxidative stress and 
glucose to produce peripheral sensory neuron 
and microvessel injury leading to diabetic 
neuropathy (Jha et al., 1995). Diabetic 
dyslipidemia is generally characterized by 
increased plasma triglyceride (TG) and 
decreased high-density lipoprotein (HDL)-
cholesterol (HDL-C) concentrations, a 
preponderance of small dense low-density 
lipoprotein (LDL), and an increased apo 
lipoprotein B concentration. Although the 
major focus on the connection between lipids 
and CHD is on LDL-cholesterol (LDL-C), the 
Adult Treatment Panel III has recognized the 
important roles of HDL-C and TGs, calling 
this combination an atherogenic dyslipidemia 
(Cleeman, 2001).  
To protect the cells and organ systems 
of the body against reactive oxygen and 
nitrogen species, organisms have evolved a 
highly sophisticated and complex antioxidants 
protection system both exogenous and 
endogenous in origin, that functions 
interactively and synergistically to neutralize 
excess free radicals. Antioxidants are also 
employed to alleviate vasomotor disturbances 
in hypercholesterolemia and to slow the 
progression of atherosclerosis (Carlene t al., 
2004). For this reason, maintenance and 
enhancement of antioxidant capacity is 
important. However, single antioxidants are 
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not generally effective in patient trials, 
probably because of the long term 
requirements for drug efficacy and the 
counterproductive effects of long term use of 
high dose single antioxidants (Jha et al., 
1995). 
In this study the effects of 
supplementing with some antioxidants 
vitamins and minerals in reversing salt-
induced dyslipidaemia and other metabolic 
syndrome-like conditions are investigated. 
 
MATERIALS AND METHODS 
Experimental animals 
Fifty five (50) adult male Sprague 
Dawley  rats (gross body weight 150-200 g) 
procured from the Animal house of Biological 
Sciences Department, Usmanu Danfodiyo 
University Sokoto were acclimatized under 
controlled conditions of humidity with regular 
light/dark cycle and had free access to food 
and water for one week before use. Following 
acclimatization, the animals were randomly 
allocated to 10 groups (n=7) and labeled as 
group 1 to 10. Salt loading was used to induce 
dyslipidaemia in Groups 2 to 10 by 
supplementing with 8% common salt in their 
diet for five (5) weeks. Group 1 was fed non-
salt supplemented diet for the same period. 
 
Antioxidants supplementation 
Group 1 served as positive control and 
was fed standard rat chow while group 2 was 
also feed standard rat chow and served as 
negative control. Group 3 was supplemented 
with vitamin A (7.16 mg/kg body weight), 
Group 4  vitamin C (16.67 mg/kg body 
weight), Group 5 vitamin E (13.17 mg/kg 
body weight), Group 6 copper (4.5 mg/kg 
body weight), Group 7 manganese (2.3 mg/kg 
body weight), Group 8 zinc (2.0 mg/kg body 
weight) , Group 9 all the vitamins combined 
and Group 10 the minerals combined, for a 
period of four (4) weeks.  
Body weight and pulse rates of the 
animals were monitored weekly. At the end of 
the experiment the animals were anaesthetized 
in chloroform vapor and blood sample 
collected by cardiac puncture for Biochemical 
analysis. Fasting blood sugar was estimated 
by glucose oxidase method (Cheesbrough, 
1992). Serum total cholesterol (TC) (Allain et 
al., 1974), high density lipoprotein  (HDL) 
(Doumas, 1975) and Triacylglycerol (TAG) 
(Cheesbrough, 1992) were also determined by 
enzymatic methods, while Low density 
lipoprotein  (LDL) and very low density 
lipoprotein (VLDL) cholesterol were 
calculated using Friedwald formula 
(Friedewald et al., 1972). Atherogenic index 
LDL/HDL and Atherogenic Index of the 




All data were expressed as mean ± 
standard deviation. Statistical analysis was 
carried out by one-way ANOVA. Post hoc test 
for multiple comparison using LSD were 
utilized to identify differences in means. 




The results of the plasma lipid profiles, 
AI and AIP are shown in Table 1. All lipid 
fractions of group 1 demonstrated normal 
baseline level. When  groups 2 to 10 were 
supplemented with 8% salt  for 5 weeks, 
dyslipidaemia occurred as indicated by 
marked increase of TCHOL, LDL and TG 
levels (p<0.05) in comparison with the levels 
in group 1. The increase of TCHOL, LDL and 
TG, FBS and AI levels of groups 2 to 10 was 
found to be about 53, 55, 79, 34 and 82% 
higher than that of group 1, respectively. It 
could be seen that 8% salt loading resulted in 
dyslipidaemia and metabolic syndrome-like 
conditions that is increased triglyceride, LDL 
cholesterol, decrease HDL cholesterol levels, 
insulin resistance and hyperglycaemia. The 
implication is that salt loading induced 
metabolic syndrome that was reversed by 
supplementation with the antioxidants. It 
could be possible that feeding the animals 
with 8% salt exerts oxidative stress but 
treating the animals with antioxidants resulted 
in the correction of the conditions even in the 
presence of the challenging agent (8% salt). 
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Table 1: Effect of supplementation on lipid profile of salt induced-hypertensive rats.  
 
















Index of Plasma 
(AIP) 
NU 1.54±0.27 0.82±0.06 0.51±0.29 0.16±0.01 0.86±0.33 3.59±0.91 0.59 -0.02 
HU 3.26±0.18a 1.81±0.07a 2.39±0.19a 0.16±0.02 0.71±0.02 5.40±0.35a 3.37a 0.41 
HTVA 0.95±0.41b 0.83±0.29b 0.17±0.10ab 0.17±0.06 0.62±0.26 3.42±0.32b 0.27b 0.13 
HTVC 0.73±0.58b 0.94±0.15b 0.14±0.10ab 0.19±0.03 0.48±0.30 4.61±0.33 0.29b 0.29 
HTVE 1.26±0.33b 0.99±0.04b 0.28±0.16b 0.19±0.01 0.79±0.17 4.20±0.28 0.35b 0.01 
HTCu 1.97±0.32b 1.29±0.91 0.84±0.43b 0.26±0.18 0.87±0.52 3.72±0.82b 0.97b 0.17 
HTMn 1.17±0.57b 0.81±0.20b 0.29±0.18b 0.16±0.04 0.75±0.35 5.01±1.0a 0.39b 0.03 
HTZn 2.81±0.79a 0.76±0.05b 0.75±0.56b 0.16±0.01 1.94±0.4ab 5.85±1.19a 0.39b -0.41 
HTAVC 2.52±0.58a 0.76±0.17b 1.14±0.83ab 0.15±0.03 1.32±0.85 4.0±0.31 0.86b -0.24 
HTAMC 2.03±0.97b 0.81±0.26b 0.81±0.04b 0.15±0.03 1.06±0.78 5.79±0.30a 0.76b -0.01 
a: values bearing “a” differ significantly from NU; while those bearing “b” differ significantly from HU using LSD; p<0.05;  NU: Normal untreated;  HU: Hypertensive untreated;  HTVA: Hypertensive 
treated with Vitamin A; HTVC: Hypertensive treated with Vitamin C;  HTVE: Hypertensive treated with Vitamin E; HTCu: Hypertensive treated with Copper; HTMn: Hypertensive treated with 
Manganese;  HTZn: Hypertensive treated with Zinc; HTAVC: Hypertensive treated with all Vitamins Combined; HTAMC: Hypertensive treated with all Minerals combined; TAG: Triacylglycerol; 
HDL-C : High density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; VLDL-C: very low density lipoprotein cholesterol;  Aix: Atherogenic index. 
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Of the vitamins, vitamin A is the most 
effective in correcting the salt-induced 
dyslipidaemia by reducing TC by up 70% and 
LDL by 93% (Table 1) but non-significantly 
(p < 0.05) reduces HDL.  It also reduced 
atherogenic index by 92% and atherogenic 
index of plasma by 68%. Vitamin C 
significantly reduced total cholesterol, 
triacylglyceride, LDL, AI, AIP and fasting 
blood glucose by 78, 48, 94, 91, 29 and 15% 
respectively. Only Vitamin E had any 
significant effect on HDL.  The minerals 
seemed to have much effect on TAG and 
HDL, where Mn and Zn normalized TAG 
with Zn increasing HDL levels three fold and 
normalized AIP. 
The results indicated that the 
antioxidants reduced significantly serum lipid 
profiles and the atherogenic index by up to 
90%. The serum glucose levels of the rats 
supplemented with antioxidant vitamins and 
minerals were also significantly (P<0.05) 
lowered compared with the negative control 
group. These results suggest that the reduction 
of serum lipid profile and glucose level may 
be due to regulation of cholesterol and 
lipoprotein metabolism and increased insulin 
sensitivity as a result of the supplementations. 
It may thus suggest that the antioxidants may 
provide protection against CVDs and 
metabolic syndrome if intervention starts 
earlier before the onset of irreversible stage. 
 
DISCUSSION 
Reactive oxygen species (ROS) 
generated in vivo is responsible for the 
oxidative damage of lipids, proteins, DNA 
and small molecules. Recent evidence also 
indicates that oxidative stress is the main 
mechanism responsible for cardiovascular 
diseases while hypercholesterolemia under 
oxidative stress is the predisposing factor for 
the progression of atherosclerosis and 
abnormal lipid metabolism. On the other 
hand, antioxidants might be able to prevent 
the impairment originated by excessive 
oxidative stress. Since endogenous 
antioxidants may not be sufficient to prevent 
damage, diet derived antioxidants could be 
important for maintaining health and 
preventing free radical-mediated diseases 
(Zulkhairi et al., 2010).  In this study 8% salt 
loading to the animals generated 
dyslipidaemia and other metabolic syndrome 
risk factors. Studies in both animals and 
human have demonstrated that prolonged high 
salt correlates with impaired endothelium 
function and pathogenesis of hypertension 
(Bragulat et al., 2001). High salt is reported to 
reduce the level nitric oxide (NO) by 
decreasing the NO synthase thus promoting 
hypertension and oxidative stress (Anees t 
al., 2007). From the results of this study it 
could be suggested that the antioxidants 
supplementation reversed the salt-induced 
dyslipidaemia and all other metabolic risk 
factors even in the present of the challenging 
agent, the salt. 
Important application of plasma lipid 
markers that is relevant to CVD risk is the 
association between the LDL to HDL ratio 
known as atherogenic index (AI). Our results 
showed that antioxidants vitamins and 
minerals had a strong hypocholesterolemic 
effects in plasma of rats with a reduction of 
plasma TCHOL, TAG, LDL and AI with only 
vitamin E, Cu, Mn, Zn and combination of the 
vitamins having significant effect on HDL 
levels (Table 1). Furthermore, the atherogenic 
index is markedly decreased due to a 
significant decrease of LDL levels. The 
observed increase of HDL is one of the most 
important criteria of an 
antihypercholesterolemic agent. Moreover, 
numerous studies have demonstrated that high 
levels of HDL are associated with a lower 
incidence of cardiovascular diseases (CVD) 
(Catherine et al., 2004). Studies have 
demonstrated that lipid lowering agents from 
several pharmacological classes reduce the 
susceptibility of LDL to oxidation, and it has 
been suggested that this is not entirely caused 
by LDL cholesterol reduction but by 
antioxidants activity (Hoffman et al., 1992). 
The increase in HDL levels observed in our 
study might be due to the stimulation of pre-
HDL and reverse cholesterol transport as 
shown by previous findings (Gupta et al., 
1993). The observed hypocholesterolaemic 
effect of the vitamin C and the antioxidant 
minerals in our study could be the basis for 
suggesting therapeutic potential of ascorbate 
in reducing atherosclerotic risk via inhibition 
of H2O2-induced oxidative stress in patients 
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with Uremia or dyslipidaemia (Chiang et al., 
2004). 
 In this study zinc supplementation was 
found to have antiatherogenic properties by 
reducing atherogenic index by 88% and 
normalizing atherogenic index of plasma, 
other researchers have demonstrated the 
antiatherogenic properties of zinc that might 
be by preventing metabolic physiologic 
derangement of the vascular endothelium 
(Hennig et al., 1996). Because of its 
antioxidant and membrane-stabilizing 
properties, zinc appears to be crucial for the 
protection against cell-destabilizing agents. 
The antiatherogenic role of zinc appears to be 
in its ability to inhibit oxidative stress 
responsive factors (Hennig et al., 1996).   
Atherogenic Index of Plasma (AIP), 
defined as log (TG/HDL-C), has recently been 
proposed as a marker of plasma atherogenicity 
because it is increased in people at higher risk 
for coronary heart disease and is inversely 
correlated with LDL particle size. AIP 
correlates with the size of pro- and anti 
atherogenic lipoprotein particles. Clinical 
studies have shown that AIP predicts 
cardiovascular risk. AIP is an easily available 
cardiovascular risk marker and a useful 
measure of response to treatment 
(pharmacological intervention) (Meng et al., 
2004). In this study Zinc was found to 
normalize AIP followed by combined 
vitamins and combined minerals. 
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